Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.

Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.

Item
http://www.wikidata.org/entity/Q34093235
Western strategy for EGJ carcinoma.Management of Locally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction: Finally a Consensus.Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy.Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation.The year in thoracic surgery: highlights from 2014.The use of neoadjuvant therapy for resectable locally advanced thoracic esophageal squamous cell carcinoma in an analysis of 5016 patients from 305 designated cancer care hospitals in Japan.Stage-directed individualized therapy in esophageal cancer.ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer.Should cT2 esophageal cancer get neoadjuvant treatment before surgery?Should cT2N0M0 be managed as a localized or locally advanced esophageal carcinoma?Management of pathologic node-positive disease following initial surgery for clinical T1-2 N0 esophageal cancer: patterns of care and outcomes from the national cancer data base.Optimal Therapy in Locally Advanced Esophageal Cancer: a National Cancer Database Analysis.Comparative effectiveness of upfront esophagectomy versus induction chemoradiation in clinical stage T2N0 esophageal cancer: A decision analysis.Induction therapy before surgery improves survival in patients with clinical T3N0 esophageal cancer: a nationwide study in Taiwan.Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma.Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
P2860

Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.

Item
http://www.wikidata.org/entity/Q34093235
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.
@ast
Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.
@en
Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.
@nl
type
label
Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.
@ast
Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.
@en
Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.
@nl
prefLabel
Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.
@ast
Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.
@en
Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.
@en
P2093
P2860
P304
P31
P356
10.1097/JTO.0000000000000228
P433
P478
P50
P577
P698
P932